Ketosis After Intake of Coconut Oil and Caprylic Acid-With and Without Glucose: A Cross-Over Study in Healthy Older Adults

Jakob Norgren, Shireen Sindi, Anna Sandebring-Matton, Ingemar Kåreholt, Makrina Daniilidou, Ulrika Akenine, Karin Nordin, Staffan Rosenborg, Tiia Ngandu, Miia Kivipelto, Jakob Norgren, Shireen Sindi, Anna Sandebring-Matton, Ingemar Kåreholt, Makrina Daniilidou, Ulrika Akenine, Karin Nordin, Staffan Rosenborg, Tiia Ngandu, Miia Kivipelto

Abstract

Introduction: Medium-chain-triglycerides (MCT), formed by fatty acids with a length of 6-12 carbon atoms (C6-C12), constitute about two thirds of coconut oil (Coc). MCT have specific metabolic properties which has led them to be described as ketogenic even in the absence of carbohydrate restriction. This effect has mainly been demonstrated for caprylic acid (C8), which constitutes about 6-8% of coconut oil. Our aim was to quantify ketosis and blood glucose after intake of Coc and C8, with and without glucose intake. Sunflower oil (Suf) was used as control, expected to not break fasting ketosis, nor induce supply-driven ketosis. Method: In a 6-arm cross-over design, 15 healthy volunteers-age 65-73, 53% women-were tested once a week. After a 12-h fast, ketones were measured during 4 h after intake of coffee with cream, in combination with each of the intervention arms in a randomized order: 1. Suf (30 g); 2. C8 (20 g) + Suf (10 g); 3. C8 (20 g) + Suf (10 g) + Glucose (50 g); 4. Coc (30 g); 5. Coc (30 g) + Glucose (50 g); 6. C8 (20 g) + Coc (30 g). The primary outcome was absolute blood levels of the ketone β-hydroxybutyrate, area under the curve (AUC). ANOVA for repeated measures was performed to compare arms. Results: β-hydroxybutyrate, AUC/time (mean ± SD), for arms were 1: 0.18 ± 0.11; 2: 0.45 ± 0.19; 3: 0.28 ± 0.12; 4: 0.22 ± 0.12; 5: 0.08 ± 0.04; 6: 0.45 ± 0.20 (mmol/L). Differences were significant (all p ≤ 0.02), except for arm 2 vs. 6, and 4 vs. 1 & 3. Blood glucose was stable in arm 1, 2, 4, & 6, at levels slightly below baseline (p ≤ 0.05) at all timepoints hours 1-4 after intake. Conclusions: C8 had a higher ketogenic effect than the other components. Coc was not significantly different from Suf, or C8 with glucose. In addition, we report that a 16-h non-carbohydrate window contributed to a mild ketosis, while blood glucose remained stable. Our results suggest that time-restricted feeding regarding carbohydrates may optimize ketosis from intake of MCT. Clinical Trial Registration: The study was registered as a clinical trial on ClinicalTrials.gov, NCT03904433.

Keywords: aged; coconut oil; fasting; glucose; ketogenic diet; ketosis; medium-chain fatty acids; β-hydroxybutyrate.

Copyright © 2020 Norgren, Sindi, Sandebring-Matton, Kåreholt, Daniilidou, Akenine, Nordin, Rosenborg, Ngandu and Kivipelto.

Figures

Figure 1
Figure 1
BHBv concentrations in blood, AUC/time, (mmol/L) during T0–T240 (minutes). Values are absolute and not adjusted for baseline levels. Suf, Sunflower oil (30 g); C8, Caprylic acid (20 g) + Sunflower oil (10 g); C8+Glu, Caprylic acid (20 g) + Sunflower oil (10 g) + Glucose (50 g); Coc, Coconut oil (30 g); Coc+Glu, Coconut oil (30 g) + Glucose (50 g); C8+Coc, Caprylic acid (20 g) + Coconut oil (30 g). BHBv, β-hydroxybutyrate in venous whole blood.
Figure 2
Figure 2
The dynamics of BHBv during T0–T240 (minutes). A descriptive graph based on absolute mean values. The arrow at T0 indicates the start of ingestion of coffee with fatty acids. The circle indicates intake of glucose (arms 3 & 5 only, striped lines), 15 min before the blood test performed immediately before T0. BHBv, β-hydroxybutyrate in venous whole blood.
Figure 3
Figure 3
Individual differences in the ketogenic response to C8. The paths of four subjects in the C8 arm (20 g Caprylic acid + 10 g Sunflower oil), selected to illustrate the big individual differences in BHBv response, and the potentially transient nature of ketosis. BHBv, β-hydroxybutyrate in venous whole blood.
Figure 4
Figure 4
The ratio between the two plasma ketones (BHBp/AcAc), plotted against BHBp. Comparisons of arms including coconut oil vs. caprylic acid (C8) vs. neither or both. For enhanced scaling, one case in arm 2 with a ratio of 11 (0.11/0.01), is excluded from the graph. BHBp, β-hydroxybutyrate in plasma; AcAc, Acetoacetate.
Figure 5
Figure 5
Descriptive dynamics of mean blood glucose during T0–T240 (minutes). T0 represent 12 h fasting values, except for arm 3 & 5 (striped), where glucose was ingested 15 min before the blood test performed immediately before T0, indicated by a circle. The arrow at T0 indicates the start of ingestion of coffee with fatty acids (5 mmol/L = 90 mg/dL).
Figure 6
Figure 6
Distribution of blood glucose levels in the four arms with a 16-h non-carbohydrate window. T0 represents time for start of ingestion of fatty acids, preceded by 12 h fasting. (5 mmol/L = 90 mg/dL).

References

    1. Cooder HR. Epilepsy in children: with particular reference to the Ketogenic Diet. Cal West Med. (1933) 39:169–73.
    1. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol. (2012) 3:59. 10.3389/fphar.2012.00059
    1. Cunnane SC, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M, Hennebelle M, et al. . Can ketones help rescue brain fuel supply in later life? implications for cognitive health during aging and the treatment of Alzheimer's disease. Front Mol Neurosci. (2016) 9:53. 10.3389/fnmol.2016.00053
    1. Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. (2013) 67:789–96. 10.1038/ejcn.2013.116
    1. Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, et al. Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther. (2018) 9:583–612. 10.1007/s13300-018-0373-9
    1. Volek JS, Noakes T, Phinney SD. Rethinking fat as a fuel for endurance exercise. Eur J Sport Sci. (2015) 15:13–20. 10.1080/17461391.2014.959564
    1. Schonfeld P, Reiser G. Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cerebral Blood Flow Metab. (2013) 33:1493–9. 10.1038/jcbfm.2013.128
    1. Poduslo SE, Miller K. Ketone-bodies as precursors for lipid-synthesis in neurons, astrocytes, and oligodendroglia (myelin) in hyperthyroidism, hyperketonemia and hypoketonemia. Neurochem Int. (1991) 18:85–8. 10.1016/0197-0186(91)90040-K
    1. Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. (2014) 25:42–52. 10.1016/j.tem.2013.09.002
    1. Dayrit FM. The properties of lauric acid and their significance in coconut oil. J Am Oil Chem Soc. (2014) 92:1–15. 10.1007/s11746-014-2562-7
    1. St-Pierre V, Vandenberghe C, Lowry CM, Fortier M, Castellano CA, Wagner R, et al. . Plasma ketone and medium chain fatty acid response in humans consuming different medium chain triglycerides during a metabolic study day. Front Nutr. (2019) 6:46. 10.3389/fnut.2019.00046
    1. Vandenberghe C, St-Pierre V, Pierotti T, Fortier M, Castellano CA, Cunnane SC. Tricaprylin alone increases plasma ketone response more than coconut oil or other medium-chain triglycerides: an acute crossover study in healthy adults. Curr Dev Nutr. (2017) 1:e000257. 10.3945/cdn.116.000257
    1. Mattson MP, Allison DB, Fontana L, Harvie M, Longo VD, Malaisse WJ, et al. . Meal frequency and timing in health and disease. Proc Natl Acad Sci USA. (2014) 111:16647–53. 10.1073/pnas.1413965111
    1. Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Res Rev. (2017) 39:46–58. 10.1016/j.arr.2016.10.005
    1. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. (1999) 15:412–26. 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>;2-8
    1. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, et al. . Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. (2007) 86:276–84. 10.1093/ajcn/86.2.276
    1. Cahill GF, Jr. Fuel metabolism in starvation. Annu Rev Nutr. (2006) 26:1–22. 10.1146/annurev.nutr.26.061505.111258
    1. Vandenberghe C, St-Pierre V, Courchesne-Loyer A, Hennebelle M, Castellano CA, Cunnane SC. Caffeine intake increases plasma ketones: an acute metabolic study in humans. Can J Physiol Pharmacol. (2017) 95:455–8. 10.1139/cjpp-2016-0338#.XocCNi2HLOQ
    1. Fortier M, Castellano CA, Croteau E, Langlois F, Bocti C, St-Pierre V, et al. . A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimers Dement. (2019) 15:625–34. 10.1016/j.jalz.2018.12.017
    1. Zilberter T, Zilberter Y. Ketogenic ratio determines metabolic effects of macronutrients and prevents interpretive bias. Front Nutr. (2018) 5:75. 10.3389/fnut.2018.00075
    1. Norgren J, Sindi S, Sandebring-Matton A, Kåreholt I, Akenine U, Nordin K, et al. . Capillary blood tests may overestimate ketosis: triangulation between three different measures of β-hydroxybutyrate. Am J Physiol Endocrinol Metab. (2020) 318:E184–E8. 10.1152/ajpendo.00454.2019
    1. McNeil CA, Pramfalk C, Humphreys SM, Hodson L. The storage stability and concentration of acetoacetate differs between blood fractions. Clin Chim Acta Int J Clin Chem. (2014) 433:278–83. 10.1016/j.cca.2014.03.033
    1. Guerci B, Tubiana-Rufi N, Bauduceau B, Bresson R, Cuperlier A, Delcroix C, et al. . Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes Metab. (2005) 31(4 Pt 1):401–6. 10.1016/S1262-3636(07)70211-2
    1. Harvey C, Schofield GM, Williden M, McQuillan JA. The effect of medium chain triglycerides on time to nutritional ketosis and symptoms of keto-induction in healthy adults: a randomised controlled clinical trial. J Nutr Metab. (2018) 2018:2630565 10.1155/2018/2630565
    1. Courchesne-Loyer A, Fortier M, Tremblay-Mercier J, Chouinard-Watkins R, Roy M, Nugent S, et al. . Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism. Nutrition. (2013) 29:635–40. 10.1016/j.nut.2012.09.009
    1. Boron WF, Boulpaep EL. Medical physiology. Philadelphia, PA: Elsevier; (2017). p. 1170–92. Available online at:
    1. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab. (2009) 6:31. 10.1186/1743-7075-6-31
    1. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. (1982) 36:950–62. 10.1093/ajcn/36.5.950
    1. Sonnay S, Chakrabarti A, Thevenet J, Wiederkehr A, Christinat N, Masoodi M. Differential metabolism of medium-chain fatty acids in differentiated human-induced pluripotent stem cell-derived astrocytes. Front Physiol. (2019) 10:657. 10.3389/fphys.2019.00657
    1. Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, et al. . Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. (2018) 17:84–93. 10.1016/S1474-4422(17)30408-8
    1. Fernando WM, Martins IJ, Goozee KG, Brennan CS, Jayasena V, Martins RN. The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action. Br J Nutr. (2015) 114:1–14. 10.1017/S0007114515001452
    1. Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, et al. . Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease. Neurosci Lett. (2019) 690:232–6. 10.1016/j.neulet.2018.10.048
    1. Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. . Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. (2004) 25:311–4. 10.1016/S0197-4580(03)00087-3
    1. Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging. (2012) 33:425 e19–27. 10.1016/j.neurobiolaging.2010.10.006
    1. Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease. Alzheimer's Dement. (2018) 4:28–36. 10.1016/j.trci.2017.11.002

Source: PubMed

3
구독하다